Evidence Details for SLC6A4
Basic Information Top
| Gene Symbol: | SLC6A4 ( 5-HTT,5-HTTLPR,5HTT,HTT,OCD1,SERT,hSERT ) |
|---|---|
| Gene Full Name: | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
| Band: | 17q11.2 |
| Quick Links | Entrez ID:6532; OMIM: 182138; Uniprot ID:SC6A4_HUMAN; ENSEMBL ID: ENSG00000108576; HGNC ID: 11050 |
| Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>SLC6A4|6532|nucleotide
ATGGAGACGACGCCCTTGAATTCTCAGAAGCAGCTATCAGCGTGTGAAGATGGAGAAGATTGTCAGGAAAACGGAGTTCTACAGAAGGTTGTTCCCACCCCAGGG
GACAAAGTGGAGTCCGGGCAAATATCCAATGGGTACTCAGCAGTTCCAAGTCCTGGTGCGGGAGATGACACACGGCACTCTATCCCAGCGACCACCACCACCCTA
GTGGCTGAGCTTCATCAAGGGGAACGGGAGACCTGGGGCAAGAAGGTGGATTTCCTTCTCTCAGTGATTGGCTATGCTGTGGACCTGGGCAATGTCTGGCGCTTC
CCCTACATATGTTACCAGAATGGAGGGGGGGCATTCCTCCTCCCCTACACCATCATGGCCATTTTTGGGGGAATCCCGCTCTTTTACATGGAGCTCGCACTGGGA
CAGTACCACCGAAATGGATGCATTTCAATATGGAGGAAAATCTGCCCGATTTTCAAAGGGATTGGTTATGCCATCTGCATCATTGCCTTTTACATTGCTTCCTAC
TACAACACCATCATGGCCTGGGCGCTATACTACCTCATCTCCTCCTTCACGGACCAGCTGCCCTGGACCAGCTGCAAGAACTCCTGGAACACTGGCAACTGCACC
AATTACTTCTCCGAGGACAACATCACCTGGACCCTCCATTCCACGTCCCCTGCTGAAGAATTTTACACGCGCCACGTCCTGCAGATCCACCGGTCTAAGGGGCTC
CAGGACCTGGGGGGCATCAGCTGGCAGCTGGCCCTCTGCATCATGCTGATCTTCACTGTTATCTACTTCAGCATCTGGAAAGGCGTCAAGACCTCTGGCAAGGTG
GTGTGGGTGACAGCCACCTTCCCTTATATCATCCTTTCTGTCCTGCTGGTGAGGGGTGCCACCCTCCCTGGAGCCTGGAGGGGTGTTCTCTTCTACTTGAAACCC
AATTGGCAGAAACTCCTGGAGACAGGGGTGTGGATAGATGCAGCCGCTCAGATCTTCTTCTCTCTTGGTCCGGGCTTTGGGGTCCTGCTGGCTTTTGCTAGCTAC
AACAAGTTCAACAACAACTGCTACCAAGATGCCCTGGTGACCAGCGTGGTGAACTGCATGACGAGCTTCGTTTCGGGATTTGTCATCTTCACAGTGCTCGGTTAC
Show »
ATGGAGACGACGCCCTTGAATTCTCAGAAGCAGCTATCAGCGTGTGAAGATGGAGAAGATTGTCAGGAAAACGGAGTTCTACAGAAGGTTGTTCCCACCCCAGGG
GACAAAGTGGAGTCCGGGCAAATATCCAATGGGTACTCAGCAGTTCCAAGTCCTGGTGCGGGAGATGACACACGGCACTCTATCCCAGCGACCACCACCACCCTA
GTGGCTGAGCTTCATCAAGGGGAACGGGAGACCTGGGGCAAGAAGGTGGATTTCCTTCTCTCAGTGATTGGCTATGCTGTGGACCTGGGCAATGTCTGGCGCTTC
CCCTACATATGTTACCAGAATGGAGGGGGGGCATTCCTCCTCCCCTACACCATCATGGCCATTTTTGGGGGAATCCCGCTCTTTTACATGGAGCTCGCACTGGGA
CAGTACCACCGAAATGGATGCATTTCAATATGGAGGAAAATCTGCCCGATTTTCAAAGGGATTGGTTATGCCATCTGCATCATTGCCTTTTACATTGCTTCCTAC
TACAACACCATCATGGCCTGGGCGCTATACTACCTCATCTCCTCCTTCACGGACCAGCTGCCCTGGACCAGCTGCAAGAACTCCTGGAACACTGGCAACTGCACC
AATTACTTCTCCGAGGACAACATCACCTGGACCCTCCATTCCACGTCCCCTGCTGAAGAATTTTACACGCGCCACGTCCTGCAGATCCACCGGTCTAAGGGGCTC
CAGGACCTGGGGGGCATCAGCTGGCAGCTGGCCCTCTGCATCATGCTGATCTTCACTGTTATCTACTTCAGCATCTGGAAAGGCGTCAAGACCTCTGGCAAGGTG
GTGTGGGTGACAGCCACCTTCCCTTATATCATCCTTTCTGTCCTGCTGGTGAGGGGTGCCACCCTCCCTGGAGCCTGGAGGGGTGTTCTCTTCTACTTGAAACCC
AATTGGCAGAAACTCCTGGAGACAGGGGTGTGGATAGATGCAGCCGCTCAGATCTTCTTCTCTCTTGGTCCGGGCTTTGGGGTCCTGCTGGCTTTTGCTAGCTAC
AACAAGTTCAACAACAACTGCTACCAAGATGCCCTGGTGACCAGCGTGGTGAACTGCATGACGAGCTTCGTTTCGGGATTTGTCATCTTCACAGTGCTCGGTTAC
Show »
>SLC6A4|6532|protein
METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRF
PYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCT
NYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKP
NWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPAS
TFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDV
Show »
METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRF
PYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCT
NYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKP
NWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPAS
TFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDV
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
| Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Score (No. of Studies) | No | 0 (0) | 0 (0) | 2 (6) | 3 (29) | 0 (0) | 0 (2) | 0 (0) | 0 (0) | 3 (13) | 40 (50) |
Syndromic Autism Gene Top
Genome-Wide Association Studies(By Ethnic Group) Top
CNV Studies Top
Linkage Studies Top
| Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
| McCauley, 2005 | - | microsatellite-based genomic screen | ![]() | ![]() | autism | 158 | - | 158 | - | 333 | - | - |
| Yonan, 2003 | USA | microsatellite-based genomic screen | ![]() | ![]() | PDD | 345 | - | 345 | - | - | - | - |
| Monaco, 2001 | - | microsatellite-based genomic screen | ![]() | ![]() | PDD | 152 | - | 152 | - | - | - | - |
| Ylisaukko-oja, 2006 | USA, Finland | microsatellite-based genomic screen | ![]() | ![]() | ASD | 314 | - | 314 | - | - | - | - |
| Spence, 2006 | USA | microsatellite-based genomic screen | ![]() | ![]() | ASD | 133 | - | 133 | - | 280 | - | - |
| Sutcliffe, 2005 | USA, AGRE | microsatellite-based genomic screen | ![]() | ![]() | ASD | 341 | - | 341 | - | - | - | - |
Low Scale Association Studies (by Ethnic Group) Top
Family Based Association Studies: 26
| Reference | Source | Platform | #Families | Affecteds | Result | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
|||||
| CAUCASIAN | ||||||||||
| Klauck, 1997_1 | Germany, Austria | PCR | 98 | 109 (25.00%) | ![]() | ![]() | ASD | 15.5±8.6 (3.5-37.3) |
68±25 (27-129) | |
| Maestrini, 1999_1 | UK(mixed) | PCR | 99 | 192 (-) | ![]() | ![]() | ASD | - - |
- - | |
| Persico, 2000_1 | Italy, USA | PCR | 91 | 98 (8.16%) | ![]() | ![]() | AD | - (3-15) |
- - | |
| Tordjman, 2001_1 | France | PCR | 69 | 71 (35.21%) | ![]() | ![]() | ASD | 11.6±4.5 (4.6-19.5) |
45.6±4.1 (45-80) | |
| Betancur, 2002_1 | PARIS | PCR | 96 | 150 (27.33%) | ![]() | ![]() | AD | 14.5 (4-44) |
- - | |
| Persico, 2002_1 | Italy | - | 156 | - (-) | ![]() | ![]() | AD | - - |
- - | |
| Kim, 2002_1 | USA | ABI PRISM 3700 Genetic Analyzer | 115 | 115 (14.78%) | ![]() | ![]() | AD | 7.1±5.2 - |
77.9±24.5 - | |
| McCauley, 2004_1 | NEMC, AGRE | FP-TDI(Acycloprime,VICTOR2) or TaqMan(ABI 7900HT Sequence Detection System) | 137 | - (-) | ![]() | ![]() | AD | - - |
- - | |
| Coutinho, 2004_1 | Portugal | Not mentioned | 105 | - (-) | ![]() | ![]() | ASD | - (2-14) |
- - | |
| Conroy, 2004_1 | Ireland | SNaPshot Method of single base extension, ABI Genetic Analyser, Genotyper (version 2.5.1) | 84 | - (-) | ![]() | ![]() | ASD | - - |
<35 - | |
| Mulder, 2005_1 | Holland | - | - | 125 (-) | ![]() | ![]() | PDD | - (5-20) |
- - | |
| Sutcliffe, 2005_1 | AGRE, USA | Taqman allelic discrimination assays | 384 | - (-) | ![]() | ![]() | ASD | - - |
- - | |
| Devlin, 2005_1 | CPEA | - | 390 | - (-) | ![]() | ![]() | ASD | - - |
- - | |
| Ramoz, 2006_1 | USA, AGRE | Illumina BeadArray technology | 352 | 645 (-) | ![]() | ![]() | AD | - - |
- - | |
| Guerini, 2006_1 | Italy | SSP-PCR, GeneAmp PCR 9700 thermocycler | 37 | 40 (30.00%) | ![]() | ![]() | ASD | 9±5 - |
- - | |
| Coutinho, 2007_1 | Portugal | the Amplifluor System or PCR-RFLP | 186 | 186 (17.24%) | ![]() | ![]() | AD | 6.8 (2-18) |
- - | |
| Longo, 2009_1 | Brazil | PCR | 105 | 151 (-) | ![]() | ![]() | ASD | - - |
- - | |
| Ma, 2009_1 | Unknown | custom Taqman SNP genotyping assays, Applied Biosystems (ABI) Taqman? SNP genotyping assays, Taqman allelic discrimination method | 290 | - (-) | ![]() | ![]() | autism | - - |
- - | |
| Anderson, 2009_1 | USA, AGRE | ABI 7900 Taqman system | 403 | - (-) | ![]() | ![]() | ASD | - (3-21) |
- - | |
| ASIAN | ||||||||||
| Yirmiya, 2001_1 | Israel | PCR | 34 | - (%) | ![]() | ![]() | AD | - - |
- - | |
| Wu, 2005_1 | China | PCR-RFLP | 175 | 175 (8.00%) | ![]() | ![]() | ASD | 6.08±2.97 - |
61.52±19.77 - | |
| Koishi, 2006_1 | Japan | - | 104 | 104 (11.54%) | ![]() | ![]() | ASD | 17.4±10.5 - |
- - | |
| Guhathakurta, 2006_1 | India | ABI PRISM 3130 Genetic Analyzer | 79 | 79 (16.67%) | ![]() | ![]() | ASD | 6.09±3.07 - |
- - | |
| Cho, 2007_1 | Korea | PCR-RFLP | 126 | 126 (13.49%) | ![]() | ![]() | ASD | 6.0±2.6 (2.2-15.4) |
65.0±27.7 (25-126) | |
| Guhathakurta, 2008_1 | India, Bangladesh, Nepal | PCR-RFLP, ABI prism 3130 Genetic Analyzer using Big dye ? v3.1 terminator chemistry of Applied Biosystems | 93 | 93 (16.67%) | ![]() | ![]() | ASD | 5.84±2.96 - |
- - | |
| MIXED/OTHERS | ||||||||||
| Cook, 1997_1 | USA | PCR | 86 | 86 (6.98%) | ![]() | ![]() | AD | 8.5±7.6 (2.5-36) |
>35 - | |
Case Control Based Association Studies: 3
| Reference | Source | Platfrom | ASD Cases | Normal Controls | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
| MIXED/OTHERS | |||||||||||
| Zhong, 1999_1 | USA | - | ![]() | ![]() | ASD | - - |
- | 92 (-) |
- - | ||
| Longo, 2009_1 | Brazil | - | ![]() | ![]() | ASD | 10.5±5.2 - |
- | 179 (43.02%) |
- - | ||
| Tassone, 2011_1 | USA | - | ![]() | ![]() | ASD | 3.8±0.9 - |
- | 137 (0.00%) |
3.4±0.8 - | ||
| Ro M, 2013_1 | Korean | Illumina GoldenGate assay | ![]() | ![]() | ASD | 15.44 - |
- | 305? (51.80%) |
36.57 - | - | |
Large Scale Expression Studies Top
NGS de novo Mutation Studies Top
| Reference | Case Number | Family Number | de novo Number | Title |
|---|---|---|---|---|
| Neale BM, 2012 | 175 | 175 | 173 | Patterns and rates of exonic de novo mutations in autism spectrum disorders. |
| De Rubeis S, 2014 | 2270 | - | 1702 | Synaptic, transcriptional and chromatin genes disrupted in autism |
NGS Mosaic SNV Studies Top
NGS Other Studies Top
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.



